nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—Glucosamine—IFNG—psoriasis	0.0143	0.705	CrCbGaD
Adenosine—Glucosamine—TNF—psoriasis	0.00599	0.295	CrCbGaD
Adenosine—ADK—Purine metabolism—CAT—psoriasis	0.00286	0.0611	CbGpPWpGaD
Adenosine—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—LEP—psoriasis	0.00282	0.0602	CbGpPWpGaD
Adenosine—DPP4—Incretin synthesis, secretion, and inactivation—LEP—psoriasis	0.00251	0.0536	CbGpPWpGaD
Adenosine—DPP4—Peptide hormone metabolism—REN—psoriasis	0.00219	0.0469	CbGpPWpGaD
Adenosine—ADA—Purine metabolism—CAT—psoriasis	0.00195	0.0416	CbGpPWpGaD
Adenosine—ADK—Nucleotide metabolism—CAT—psoriasis	0.00144	0.0307	CbGpPWpGaD
Adenosine—ADA—Validated transcriptional targets of deltaNp63 isoforms—VDR—psoriasis	0.00142	0.0304	CbGpPWpGaD
Adenosine—DPP4—Peptide hormone metabolism—ACE—psoriasis	0.00137	0.0293	CbGpPWpGaD
Adenosine—ADA—Validated transcriptional targets of TAp63 isoforms—VDR—psoriasis	0.00127	0.0272	CbGpPWpGaD
Adenosine—ADORA1—G alpha (i) signalling events—HCAR2—psoriasis	0.00111	0.0237	CbGpPWpGaD
Adenosine—Bradycardia—Betamethasone—psoriasis	0.00109	0.00116	CcSEcCtD
Adenosine—Bradycardia—Dexamethasone—psoriasis	0.00109	0.00116	CcSEcCtD
Adenosine—Hypersensitivity—Hydroxyurea—psoriasis	0.00109	0.00116	CcSEcCtD
Adenosine—Syncope—Mycophenolate mofetil—psoriasis	0.00107	0.00115	CcSEcCtD
Adenosine—Cough—Cyclosporine—psoriasis	0.00107	0.00114	CcSEcCtD
Adenosine—Mood swings—Methotrexate—psoriasis	0.00106	0.00114	CcSEcCtD
Adenosine—Convulsion—Cyclosporine—psoriasis	0.00106	0.00114	CcSEcCtD
Adenosine—Asthenia—Hydroxyurea—psoriasis	0.00106	0.00113	CcSEcCtD
Adenosine—Hypertension—Cyclosporine—psoriasis	0.00106	0.00113	CcSEcCtD
Adenosine—Pain—Mycophenolic acid—psoriasis	0.00106	0.00113	CcSEcCtD
Adenosine—Palpitations—Mycophenolate mofetil—psoriasis	0.00105	0.00113	CcSEcCtD
Adenosine—Arrhythmia—Triamcinolone—psoriasis	0.00105	0.00113	CcSEcCtD
Adenosine—Vision blurred—Prednisolone—psoriasis	0.00105	0.00112	CcSEcCtD
Adenosine—Loss of consciousness—Mycophenolate mofetil—psoriasis	0.00105	0.00112	CcSEcCtD
Adenosine—Chest pain—Cyclosporine—psoriasis	0.00104	0.00112	CcSEcCtD
Adenosine—Cough—Mycophenolate mofetil—psoriasis	0.00104	0.00112	CcSEcCtD
Adenosine—Anxiety—Cyclosporine—psoriasis	0.00104	0.00111	CcSEcCtD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.00104	0.0221	CbGpPWpGaD
Adenosine—Convulsion—Mycophenolate mofetil—psoriasis	0.00103	0.00111	CcSEcCtD
Adenosine—Hypertension—Mycophenolate mofetil—psoriasis	0.00103	0.0011	CcSEcCtD
Adenosine—Discomfort—Cyclosporine—psoriasis	0.00103	0.0011	CcSEcCtD
Adenosine—Acute coronary syndrome—Prednisone—psoriasis	0.00102	0.00109	CcSEcCtD
Adenosine—Dry mouth—Cyclosporine—psoriasis	0.00102	0.00109	CcSEcCtD
Adenosine—Angioedema—Prednisolone—psoriasis	0.00102	0.00109	CcSEcCtD
Adenosine—Chest pain—Mycophenolate mofetil—psoriasis	0.00102	0.00109	CcSEcCtD
Adenosine—Myocardial infarction—Prednisone—psoriasis	0.00101	0.00109	CcSEcCtD
Adenosine—Anxiety—Mycophenolate mofetil—psoriasis	0.00101	0.00109	CcSEcCtD
Adenosine—Discomfort—Mycophenolate mofetil—psoriasis	0.001	0.00108	CcSEcCtD
Adenosine—Dysgeusia—Triamcinolone—psoriasis	0.001	0.00107	CcSEcCtD
Adenosine—Anaphylactic shock—Cyclosporine—psoriasis	0.000998	0.00107	CcSEcCtD
Adenosine—Syncope—Prednisolone—psoriasis	0.000998	0.00107	CcSEcCtD
Adenosine—Dry mouth—Mycophenolate mofetil—psoriasis	0.000993	0.00106	CcSEcCtD
Adenosine—Angioedema—Hydrocortisone—psoriasis	0.000993	0.00106	CcSEcCtD
Adenosine—Back pain—Triamcinolone—psoriasis	0.00099	0.00106	CcSEcCtD
Adenosine—Loss of consciousness—Prednisolone—psoriasis	0.000978	0.00105	CcSEcCtD
Adenosine—ADA—Nucleotide metabolism—CAT—psoriasis	0.000978	0.0209	CbGpPWpGaD
Adenosine—Syncope—Hydrocortisone—psoriasis	0.000975	0.00105	CcSEcCtD
Adenosine—Dizziness—Hydroxyurea—psoriasis	0.000974	0.00104	CcSEcCtD
Adenosine—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000974	0.00104	CcSEcCtD
Adenosine—Hyperhidrosis—Cyclosporine—psoriasis	0.000965	0.00103	CcSEcCtD
Adenosine—Convulsion—Prednisolone—psoriasis	0.000964	0.00103	CcSEcCtD
Adenosine—Hypertension—Prednisolone—psoriasis	0.000961	0.00103	CcSEcCtD
Adenosine—Shock—Mycophenolate mofetil—psoriasis	0.000958	0.00103	CcSEcCtD
Adenosine—Loss of consciousness—Hydrocortisone—psoriasis	0.000955	0.00102	CcSEcCtD
Adenosine—Arrhythmia—Betamethasone—psoriasis	0.000953	0.00102	CcSEcCtD
Adenosine—Arrhythmia—Dexamethasone—psoriasis	0.000953	0.00102	CcSEcCtD
Adenosine—Tachycardia—Mycophenolate mofetil—psoriasis	0.00095	0.00102	CcSEcCtD
Adenosine—Bradycardia—Prednisone—psoriasis	0.000946	0.00101	CcSEcCtD
Adenosine—Convulsion—Hydrocortisone—psoriasis	0.000942	0.00101	CcSEcCtD
Adenosine—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000941	0.00101	CcSEcCtD
Adenosine—Hypertension—Hydrocortisone—psoriasis	0.000939	0.00101	CcSEcCtD
Adenosine—Vomiting—Hydroxyurea—psoriasis	0.000937	0.001	CcSEcCtD
Adenosine—Discomfort—Prednisolone—psoriasis	0.000936	0.001	CcSEcCtD
Adenosine—SLC28A3—SLC-mediated transmembrane transport—CP—psoriasis	0.000936	0.02	CbGpPWpGaD
Adenosine—Angioedema—Triamcinolone—psoriasis	0.000935	0.001	CcSEcCtD
Adenosine—Abdominal discomfort—Methotrexate—psoriasis	0.00093	0.000997	CcSEcCtD
Adenosine—Rash—Hydroxyurea—psoriasis	0.000929	0.000996	CcSEcCtD
Adenosine—Dermatitis—Hydroxyurea—psoriasis	0.000928	0.000995	CcSEcCtD
Adenosine—Headache—Hydroxyurea—psoriasis	0.000923	0.000989	CcSEcCtD
Adenosine—Anxiety—Hydrocortisone—psoriasis	0.000922	0.000989	CcSEcCtD
Adenosine—Syncope—Triamcinolone—psoriasis	0.000918	0.000984	CcSEcCtD
Adenosine—Discomfort—Hydrocortisone—psoriasis	0.000914	0.00098	CcSEcCtD
Adenosine—Hypotension—Mycophenolate mofetil—psoriasis	0.00091	0.000975	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.00091	0.000975	CcSEcCtD
Adenosine—Anaphylactic shock—Prednisolone—psoriasis	0.000908	0.000974	CcSEcCtD
Adenosine—Loss of consciousness—Triamcinolone—psoriasis	0.0009	0.000964	CcSEcCtD
Adenosine—Paraesthesia—Cyclosporine—psoriasis	0.000896	0.000961	CcSEcCtD
Adenosine—Shock—Prednisolone—psoriasis	0.000894	0.000958	CcSEcCtD
Adenosine—Cough—Triamcinolone—psoriasis	0.000893	0.000957	CcSEcCtD
Adenosine—Dyspnoea—Cyclosporine—psoriasis	0.00089	0.000954	CcSEcCtD
Adenosine—Somnolence—Cyclosporine—psoriasis	0.000887	0.000951	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000887	0.000951	CcSEcCtD
Adenosine—Anaphylactic shock—Hydrocortisone—psoriasis	0.000887	0.000951	CcSEcCtD
Adenosine—Convulsion—Triamcinolone—psoriasis	0.000887	0.000951	CcSEcCtD
Adenosine—Tachycardia—Prednisolone—psoriasis	0.000887	0.00095	CcSEcCtD
Adenosine—Asthenia—Mycophenolic acid—psoriasis	0.000885	0.000949	CcSEcCtD
Adenosine—Hypertension—Triamcinolone—psoriasis	0.000884	0.000947	CcSEcCtD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000881	0.0188	CbGpPWpGaD
Adenosine—Hyperhidrosis—Prednisolone—psoriasis	0.000878	0.000941	CcSEcCtD
Adenosine—Nausea—Hydroxyurea—psoriasis	0.000875	0.000938	CcSEcCtD
Adenosine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000874	0.000937	CcSEcCtD
Adenosine—Shock—Hydrocortisone—psoriasis	0.000873	0.000936	CcSEcCtD
Adenosine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000868	0.000931	CcSEcCtD
Adenosine—Tachycardia—Hydrocortisone—psoriasis	0.000866	0.000928	CcSEcCtD
Adenosine—Somnolence—Mycophenolate mofetil—psoriasis	0.000866	0.000928	CcSEcCtD
Adenosine—Drowsiness—Methotrexate—psoriasis	0.000865	0.000927	CcSEcCtD
Adenosine—Flushing—Prednisone—psoriasis	0.000862	0.000924	CcSEcCtD
Adenosine—Discomfort—Triamcinolone—psoriasis	0.000861	0.000923	CcSEcCtD
Adenosine—Hyperhidrosis—Hydrocortisone—psoriasis	0.000858	0.000919	CcSEcCtD
Adenosine—Pain—Cyclosporine—psoriasis	0.000854	0.000915	CcSEcCtD
Adenosine—Dry mouth—Triamcinolone—psoriasis	0.000852	0.000914	CcSEcCtD
Adenosine—DPP4—Peptide hormone metabolism—LEP—psoriasis	0.000851	0.0182	CbGpPWpGaD
Adenosine—Angioedema—Betamethasone—psoriasis	0.000849	0.00091	CcSEcCtD
Adenosine—Angioedema—Dexamethasone—psoriasis	0.000849	0.00091	CcSEcCtD
Adenosine—Anaphylactic shock—Triamcinolone—psoriasis	0.000835	0.000895	CcSEcCtD
Adenosine—Syncope—Betamethasone—psoriasis	0.000833	0.000893	CcSEcCtD
Adenosine—Syncope—Dexamethasone—psoriasis	0.000833	0.000893	CcSEcCtD
Adenosine—Pain—Mycophenolate mofetil—psoriasis	0.000833	0.000893	CcSEcCtD
Adenosine—Arrhythmia—Prednisone—psoriasis	0.00083	0.00089	CcSEcCtD
Adenosine—Sweating—Methotrexate—psoriasis	0.000829	0.000889	CcSEcCtD
Adenosine—Hypotension—Hydrocortisone—psoriasis	0.000829	0.000889	CcSEcCtD
Adenosine—Shock—Triamcinolone—psoriasis	0.000822	0.000881	CcSEcCtD
Adenosine—Loss of consciousness—Betamethasone—psoriasis	0.000816	0.000875	CcSEcCtD
Adenosine—Loss of consciousness—Dexamethasone—psoriasis	0.000816	0.000875	CcSEcCtD
Adenosine—Dizziness—Mycophenolic acid—psoriasis	0.000816	0.000875	CcSEcCtD
Adenosine—Paraesthesia—Prednisolone—psoriasis	0.000816	0.000874	CcSEcCtD
Adenosine—Tachycardia—Triamcinolone—psoriasis	0.000815	0.000874	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000808	0.000866	CcSEcCtD
Adenosine—Hyperhidrosis—Triamcinolone—psoriasis	0.000808	0.000866	CcSEcCtD
Adenosine—Convulsion—Betamethasone—psoriasis	0.000805	0.000863	CcSEcCtD
Adenosine—Convulsion—Dexamethasone—psoriasis	0.000805	0.000863	CcSEcCtD
Adenosine—Hypertension—Dexamethasone—psoriasis	0.000802	0.00086	CcSEcCtD
Adenosine—Hypertension—Betamethasone—psoriasis	0.000802	0.00086	CcSEcCtD
Adenosine—Paraesthesia—Hydrocortisone—psoriasis	0.000797	0.000854	CcSEcCtD
Adenosine—Urticaria—Cyclosporine—psoriasis	0.000793	0.00085	CcSEcCtD
Adenosine—ADORA2B—GPCR ligand binding—HCAR2—psoriasis	0.000789	0.0169	CbGpPWpGaD
Adenosine—Anxiety—Dexamethasone—psoriasis	0.000788	0.000845	CcSEcCtD
Adenosine—Anxiety—Betamethasone—psoriasis	0.000788	0.000845	CcSEcCtD
Adenosine—Vomiting—Mycophenolic acid—psoriasis	0.000785	0.000841	CcSEcCtD
Adenosine—Discomfort—Dexamethasone—psoriasis	0.000781	0.000837	CcSEcCtD
Adenosine—Discomfort—Betamethasone—psoriasis	0.000781	0.000837	CcSEcCtD
Adenosine—Rash—Mycophenolic acid—psoriasis	0.000778	0.000834	CcSEcCtD
Adenosine—Dermatitis—Mycophenolic acid—psoriasis	0.000777	0.000833	CcSEcCtD
Adenosine—Pain—Prednisolone—psoriasis	0.000777	0.000833	CcSEcCtD
Adenosine—Urticaria—Mycophenolate mofetil—psoriasis	0.000774	0.000829	CcSEcCtD
Adenosine—Headache—Mycophenolic acid—psoriasis	0.000773	0.000829	CcSEcCtD
Adenosine—Vision blurred—Prednisone—psoriasis	0.000762	0.000817	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000761	0.000816	CcSEcCtD
Adenosine—Pain—Hydrocortisone—psoriasis	0.000759	0.000813	CcSEcCtD
Adenosine—Anaphylactic shock—Betamethasone—psoriasis	0.000758	0.000813	CcSEcCtD
Adenosine—Anaphylactic shock—Dexamethasone—psoriasis	0.000758	0.000813	CcSEcCtD
Adenosine—Paraesthesia—Triamcinolone—psoriasis	0.00075	0.000804	CcSEcCtD
Adenosine—Shock—Betamethasone—psoriasis	0.000746	0.000799	CcSEcCtD
Adenosine—Shock—Dexamethasone—psoriasis	0.000746	0.000799	CcSEcCtD
Adenosine—Dyspnoea—Triamcinolone—psoriasis	0.000745	0.000798	CcSEcCtD
Adenosine—Agitation—Prednisone—psoriasis	0.000743	0.000797	CcSEcCtD
Adenosine—Tachycardia—Betamethasone—psoriasis	0.00074	0.000793	CcSEcCtD
Adenosine—Tachycardia—Dexamethasone—psoriasis	0.00074	0.000793	CcSEcCtD
Adenosine—Angioedema—Prednisone—psoriasis	0.000739	0.000792	CcSEcCtD
Adenosine—Hypersensitivity—Cyclosporine—psoriasis	0.000735	0.000788	CcSEcCtD
Adenosine—Nausea—Mycophenolic acid—psoriasis	0.000733	0.000786	CcSEcCtD
Adenosine—Hyperhidrosis—Dexamethasone—psoriasis	0.000733	0.000785	CcSEcCtD
Adenosine—Hyperhidrosis—Betamethasone—psoriasis	0.000733	0.000785	CcSEcCtD
Adenosine—Syncope—Prednisone—psoriasis	0.000725	0.000778	CcSEcCtD
Adenosine—Tinnitus—Methotrexate—psoriasis	0.000724	0.000776	CcSEcCtD
Adenosine—Urticaria—Prednisolone—psoriasis	0.000722	0.000774	CcSEcCtD
Adenosine—Cardiac disorder—Methotrexate—psoriasis	0.000721	0.000773	CcSEcCtD
Adenosine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000717	0.000769	CcSEcCtD
Adenosine—Asthenia—Cyclosporine—psoriasis	0.000716	0.000768	CcSEcCtD
Adenosine—Pain—Triamcinolone—psoriasis	0.000714	0.000766	CcSEcCtD
Adenosine—Loss of consciousness—Prednisone—psoriasis	0.000711	0.000762	CcSEcCtD
Adenosine—Hypotension—Dexamethasone—psoriasis	0.000708	0.000759	CcSEcCtD
Adenosine—Hypotension—Betamethasone—psoriasis	0.000708	0.000759	CcSEcCtD
Adenosine—Urticaria—Hydrocortisone—psoriasis	0.000705	0.000756	CcSEcCtD
Adenosine—Convulsion—Prednisone—psoriasis	0.000701	0.000751	CcSEcCtD
Adenosine—Mediastinal disorder—Methotrexate—psoriasis	0.0007	0.00075	CcSEcCtD
Adenosine—Asthenia—Mycophenolate mofetil—psoriasis	0.000699	0.000749	CcSEcCtD
Adenosine—Hypertension—Prednisone—psoriasis	0.000698	0.000749	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000691	0.00074	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000691	0.00074	CcSEcCtD
Adenosine—Anxiety—Prednisone—psoriasis	0.000686	0.000736	CcSEcCtD
Adenosine—Paraesthesia—Dexamethasone—psoriasis	0.000681	0.00073	CcSEcCtD
Adenosine—Paraesthesia—Betamethasone—psoriasis	0.000681	0.00073	CcSEcCtD
Adenosine—Discomfort—Prednisone—psoriasis	0.00068	0.000729	CcSEcCtD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.00068	0.0145	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—HCAR2—psoriasis	0.000671	0.0143	CbGpPWpGaD
Adenosine—Hypersensitivity—Prednisolone—psoriasis	0.000669	0.000717	CcSEcCtD
Adenosine—Urticaria—Triamcinolone—psoriasis	0.000664	0.000711	CcSEcCtD
Adenosine—Dysgeusia—Methotrexate—psoriasis	0.000662	0.00071	CcSEcCtD
Adenosine—Dizziness—Cyclosporine—psoriasis	0.00066	0.000708	CcSEcCtD
Adenosine—Anaphylactic shock—Prednisone—psoriasis	0.00066	0.000708	CcSEcCtD
Adenosine—Back pain—Methotrexate—psoriasis	0.000654	0.000701	CcSEcCtD
Adenosine—Hypersensitivity—Hydrocortisone—psoriasis	0.000654	0.000701	CcSEcCtD
Adenosine—Shock—Prednisone—psoriasis	0.000649	0.000696	CcSEcCtD
Adenosine—Pain—Betamethasone—psoriasis	0.000648	0.000695	CcSEcCtD
Adenosine—Pain—Dexamethasone—psoriasis	0.000648	0.000695	CcSEcCtD
Adenosine—Tachycardia—Prednisone—psoriasis	0.000644	0.000691	CcSEcCtD
Adenosine—Dizziness—Mycophenolate mofetil—psoriasis	0.000644	0.00069	CcSEcCtD
Adenosine—Hyperhidrosis—Prednisone—psoriasis	0.000638	0.000684	CcSEcCtD
Adenosine—Vision blurred—Methotrexate—psoriasis	0.000637	0.000683	CcSEcCtD
Adenosine—Asthenia—Hydrocortisone—psoriasis	0.000637	0.000682	CcSEcCtD
Adenosine—Vomiting—Cyclosporine—psoriasis	0.000635	0.00068	CcSEcCtD
Adenosine—Rash—Cyclosporine—psoriasis	0.000629	0.000675	CcSEcCtD
Adenosine—Dermatitis—Cyclosporine—psoriasis	0.000629	0.000674	CcSEcCtD
Adenosine—Headache—Cyclosporine—psoriasis	0.000625	0.00067	CcSEcCtD
Adenosine—Vomiting—Mycophenolate mofetil—psoriasis	0.000619	0.000664	CcSEcCtD
Adenosine—Hypersensitivity—Triamcinolone—psoriasis	0.000615	0.00066	CcSEcCtD
Adenosine—Rash—Mycophenolate mofetil—psoriasis	0.000614	0.000658	CcSEcCtD
Adenosine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000613	0.000658	CcSEcCtD
Adenosine—Headache—Mycophenolate mofetil—psoriasis	0.00061	0.000654	CcSEcCtD
Adenosine—Urticaria—Dexamethasone—psoriasis	0.000602	0.000645	CcSEcCtD
Adenosine—Urticaria—Betamethasone—psoriasis	0.000602	0.000645	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Prednisone—psoriasis	0.000601	0.000645	CcSEcCtD
Adenosine—Dizziness—Prednisolone—psoriasis	0.000601	0.000644	CcSEcCtD
Adenosine—Asthenia—Triamcinolone—psoriasis	0.000599	0.000642	CcSEcCtD
Adenosine—Nausea—Cyclosporine—psoriasis	0.000593	0.000636	CcSEcCtD
Adenosine—Paraesthesia—Prednisone—psoriasis	0.000593	0.000635	CcSEcCtD
Adenosine—Cough—Methotrexate—psoriasis	0.00059	0.000632	CcSEcCtD
Adenosine—Dizziness—Hydrocortisone—psoriasis	0.000587	0.000629	CcSEcCtD
Adenosine—Convulsion—Methotrexate—psoriasis	0.000586	0.000628	CcSEcCtD
Adenosine—Nausea—Mycophenolate mofetil—psoriasis	0.000578	0.00062	CcSEcCtD
Adenosine—ADORA1—G alpha (i) signalling events—CCL20—psoriasis	0.000576	0.0123	CbGpPWpGaD
Adenosine—Chest pain—Methotrexate—psoriasis	0.000575	0.000617	CcSEcCtD
Adenosine—Rash—Prednisolone—psoriasis	0.000573	0.000614	CcSEcCtD
Adenosine—Dermatitis—Prednisolone—psoriasis	0.000572	0.000613	CcSEcCtD
Adenosine—Headache—Prednisolone—psoriasis	0.000569	0.00061	CcSEcCtD
Adenosine—Discomfort—Methotrexate—psoriasis	0.000569	0.000609	CcSEcCtD
Adenosine—Vomiting—Hydrocortisone—psoriasis	0.000564	0.000605	CcSEcCtD
Adenosine—Rash—Hydrocortisone—psoriasis	0.000559	0.0006	CcSEcCtD
Adenosine—Dermatitis—Hydrocortisone—psoriasis	0.000559	0.000599	CcSEcCtD
Adenosine—Headache—Hydrocortisone—psoriasis	0.000556	0.000596	CcSEcCtD
Adenosine—Dizziness—Triamcinolone—psoriasis	0.000552	0.000592	CcSEcCtD
Adenosine—Anaphylactic shock—Methotrexate—psoriasis	0.000552	0.000591	CcSEcCtD
Adenosine—Asthenia—Dexamethasone—psoriasis	0.000544	0.000583	CcSEcCtD
Adenosine—Asthenia—Betamethasone—psoriasis	0.000544	0.000583	CcSEcCtD
Adenosine—Nausea—Prednisolone—psoriasis	0.00054	0.000578	CcSEcCtD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000538	0.0115	CbGpPWpGaD
Adenosine—Hyperhidrosis—Methotrexate—psoriasis	0.000533	0.000572	CcSEcCtD
Adenosine—Vomiting—Triamcinolone—psoriasis	0.000531	0.000569	CcSEcCtD
Adenosine—Nausea—Hydrocortisone—psoriasis	0.000527	0.000565	CcSEcCtD
Adenosine—Rash—Triamcinolone—psoriasis	0.000527	0.000565	CcSEcCtD
Adenosine—Dermatitis—Triamcinolone—psoriasis	0.000526	0.000564	CcSEcCtD
Adenosine—Urticaria—Prednisone—psoriasis	0.000524	0.000562	CcSEcCtD
Adenosine—Headache—Triamcinolone—psoriasis	0.000523	0.000561	CcSEcCtD
Adenosine—ADORA2A—GPCR ligand binding—HCAR2—psoriasis	0.000518	0.0111	CbGpPWpGaD
Adenosine—Hypotension—Methotrexate—psoriasis	0.000515	0.000553	CcSEcCtD
Adenosine—ADK—Metabolism—NDUFA5—psoriasis	0.000512	0.0109	CbGpPWpGaD
Adenosine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000503	0.000539	CcSEcCtD
Adenosine—Dizziness—Dexamethasone—psoriasis	0.000501	0.000537	CcSEcCtD
Adenosine—Dizziness—Betamethasone—psoriasis	0.000501	0.000537	CcSEcCtD
Adenosine—Nausea—Triamcinolone—psoriasis	0.000496	0.000532	CcSEcCtD
Adenosine—Paraesthesia—Methotrexate—psoriasis	0.000495	0.000531	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—CD4—psoriasis	0.000494	0.0106	CbGpPWpGaD
Adenosine—Dyspnoea—Methotrexate—psoriasis	0.000492	0.000527	CcSEcCtD
Adenosine—Somnolence—Methotrexate—psoriasis	0.00049	0.000526	CcSEcCtD
Adenosine—Hypersensitivity—Prednisone—psoriasis	0.000486	0.000521	CcSEcCtD
Adenosine—Vomiting—Dexamethasone—psoriasis	0.000482	0.000517	CcSEcCtD
Adenosine—Vomiting—Betamethasone—psoriasis	0.000482	0.000517	CcSEcCtD
Adenosine—Rash—Dexamethasone—psoriasis	0.000478	0.000512	CcSEcCtD
Adenosine—Rash—Betamethasone—psoriasis	0.000478	0.000512	CcSEcCtD
Adenosine—Dermatitis—Dexamethasone—psoriasis	0.000477	0.000512	CcSEcCtD
Adenosine—Dermatitis—Betamethasone—psoriasis	0.000477	0.000512	CcSEcCtD
Adenosine—SLC28A3—Transmembrane transport of small molecules—CP—psoriasis	0.000476	0.0102	CbGpPWpGaD
Adenosine—Headache—Betamethasone—psoriasis	0.000475	0.000509	CcSEcCtD
Adenosine—Headache—Dexamethasone—psoriasis	0.000475	0.000509	CcSEcCtD
Adenosine—Asthenia—Prednisone—psoriasis	0.000474	0.000508	CcSEcCtD
Adenosine—Pain—Methotrexate—psoriasis	0.000472	0.000506	CcSEcCtD
Adenosine—ADORA2A—HIF-2-alpha transcription factor network—VEGFA—psoriasis	0.000458	0.00978	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000458	0.00978	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—CARM1—psoriasis	0.000454	0.00969	CbGpPWpGaD
Adenosine—Nausea—Dexamethasone—psoriasis	0.00045	0.000483	CcSEcCtD
Adenosine—Nausea—Betamethasone—psoriasis	0.00045	0.000483	CcSEcCtD
Adenosine—ADORA2B—GPCR downstream signaling—HCAR2—psoriasis	0.000446	0.00952	CbGpPWpGaD
Adenosine—Urticaria—Methotrexate—psoriasis	0.000438	0.00047	CcSEcCtD
Adenosine—Dizziness—Prednisone—psoriasis	0.000437	0.000468	CcSEcCtD
Adenosine—ADK—Metabolism—CYP2S1—psoriasis	0.000435	0.00929	CbGpPWpGaD
Adenosine—ADORA2B—C-MYB transcription factor network—CD4—psoriasis	0.000432	0.00924	CbGpPWpGaD
Adenosine—Vomiting—Prednisone—psoriasis	0.00042	0.00045	CcSEcCtD
Adenosine—Rash—Prednisone—psoriasis	0.000416	0.000446	CcSEcCtD
Adenosine—Dermatitis—Prednisone—psoriasis	0.000416	0.000446	CcSEcCtD
Adenosine—DPP4—Metabolism of proteins—REN—psoriasis	0.000414	0.00885	CbGpPWpGaD
Adenosine—Headache—Prednisone—psoriasis	0.000414	0.000443	CcSEcCtD
Adenosine—ADORA2A—Monoamine Transport—TNF—psoriasis	0.000412	0.00879	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CCL20—psoriasis	0.00041	0.00875	CbGpPWpGaD
Adenosine—Hypersensitivity—Methotrexate—psoriasis	0.000406	0.000436	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—HCAR2—psoriasis	0.000405	0.00865	CbGpPWpGaD
Adenosine—Asthenia—Methotrexate—psoriasis	0.000396	0.000424	CcSEcCtD
Adenosine—Nausea—Prednisone—psoriasis	0.000392	0.00042	CcSEcCtD
Adenosine—ADORA1—GPCR downstream signaling—HCAR2—psoriasis	0.000379	0.0081	CbGpPWpGaD
Adenosine—Dizziness—Methotrexate—psoriasis	0.000365	0.000391	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—LEP—psoriasis	0.000356	0.00761	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000353	0.00755	CbGpPWpGaD
Adenosine—Vomiting—Methotrexate—psoriasis	0.000351	0.000376	CcSEcCtD
Adenosine—ADORA1—GPCR ligand binding—CCL20—psoriasis	0.000349	0.00744	CbGpPWpGaD
Adenosine—Rash—Methotrexate—psoriasis	0.000348	0.000373	CcSEcCtD
Adenosine—ADA—Metabolism—NDUFA5—psoriasis	0.000348	0.00743	CbGpPWpGaD
Adenosine—Dermatitis—Methotrexate—psoriasis	0.000348	0.000373	CcSEcCtD
Adenosine—Headache—Methotrexate—psoriasis	0.000346	0.00037	CcSEcCtD
Adenosine—ADORA1—Signaling by GPCR—HCAR2—psoriasis	0.000344	0.00735	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—NOS2—psoriasis	0.000332	0.00709	CbGpPWpGaD
Adenosine—Nausea—Methotrexate—psoriasis	0.000328	0.000351	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—PPARG—psoriasis	0.00031	0.00663	CbGpPWpGaD
Adenosine—ADA—Metabolism—CYP2S1—psoriasis	0.000296	0.00632	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—HCAR2—psoriasis	0.000293	0.00625	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CCL20—psoriasis	0.000269	0.00575	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—HCAR2—psoriasis	0.000266	0.00568	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—LEP—psoriasis	0.000265	0.00566	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—ACE—psoriasis	0.000259	0.00552	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—NOS2—psoriasis	0.000247	0.00528	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HCAR2—psoriasis	0.000239	0.00511	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CCL20—psoriasis	0.000232	0.00495	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—PPARG—psoriasis	0.000231	0.00493	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—JUN—psoriasis	0.00022	0.0047	CbGpPWpGaD
Adenosine—ADK—Metabolism—CARM1—psoriasis	0.000212	0.00454	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CCL20—psoriasis	0.00021	0.00449	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TAGAP—psoriasis	0.000207	0.00443	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—LEP—psoriasis	0.000205	0.00437	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HCAR2—psoriasis	0.000203	0.00434	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CCL20—psoriasis	0.000197	0.00421	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—NOS2—psoriasis	0.000191	0.00407	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCL20—psoriasis	0.000179	0.00382	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—PPARG—psoriasis	0.000178	0.00381	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TAGAP—psoriasis	0.000176	0.00377	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—JUN—psoriasis	0.000164	0.0035	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—LEP—psoriasis	0.000161	0.00343	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HCAR2—psoriasis	0.000157	0.00335	CbGpPWpGaD
Adenosine—ADORA1—G alpha (i) signalling events—CXCL8—psoriasis	0.000155	0.00332	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—TYK2—psoriasis	0.000153	0.00327	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CCL20—psoriasis	0.000152	0.00325	CbGpPWpGaD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000145	0.0031	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—TP53—psoriasis	0.000145	0.0031	CbGpPWpGaD
Adenosine—ADA—Metabolism—CARM1—psoriasis	0.000144	0.00308	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—NFKBIA—psoriasis	0.000144	0.00307	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCL20—psoriasis	0.000138	0.00295	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TAGAP—psoriasis	0.000136	0.00291	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—IL6—psoriasis	0.000133	0.00284	CbGpPWpGaD
Adenosine—ADK—Metabolism—CAT—psoriasis	0.000131	0.00279	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—JUN—psoriasis	0.000126	0.0027	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCL20—psoriasis	0.000124	0.00265	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000124	0.00264	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—TYK2—psoriasis	0.000118	0.00252	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CXCL8—psoriasis	0.000111	0.00236	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—TP53—psoriasis	0.000108	0.00231	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—psoriasis	0.000107	0.00229	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—CXCL8—psoriasis	0.000107	0.00228	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCL20—psoriasis	0.000106	0.00226	CbGpPWpGaD
Adenosine—ADK—Metabolism—APOE—psoriasis	0.000102	0.00217	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—IL6—psoriasis	9.89e-05	0.00211	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	9.54e-05	0.00204	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CXCL8—psoriasis	9.41e-05	0.00201	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—NFKB1—psoriasis	9.18e-05	0.00196	CbGpPWpGaD
Adenosine—ADA—Metabolism—CAT—psoriasis	8.88e-05	0.0019	CbGpPWpGaD
Adenosine—ADK—Metabolism—PPARG—psoriasis	8.84e-05	0.00189	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—TP53—psoriasis	8.35e-05	0.00178	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—STAT3—psoriasis	8.25e-05	0.00176	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCL20—psoriasis	8.16e-05	0.00174	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—IL6—psoriasis	7.64e-05	0.00163	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	7.49e-05	0.0016	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CXCL8—psoriasis	7.27e-05	0.00155	CbGpPWpGaD
Adenosine—ADA—Metabolism—APOE—psoriasis	6.9e-05	0.00147	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SOCS1—psoriasis	6.84e-05	0.00146	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—TYK2—psoriasis	6.52e-05	0.00139	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CXCL8—psoriasis	6.26e-05	0.00134	CbGpPWpGaD
Adenosine—ADA—Metabolism—PPARG—psoriasis	6.01e-05	0.00128	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SOCS1—psoriasis	5.82e-05	0.00124	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—IL6—psoriasis	5.76e-05	0.00123	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CXCL8—psoriasis	5.68e-05	0.00121	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—TYK2—psoriasis	5.55e-05	0.00118	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CXCL8—psoriasis	5.32e-05	0.00114	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—LEP—psoriasis	5.05e-05	0.00108	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APOE—psoriasis	5.05e-05	0.00108	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCL8—psoriasis	4.83e-05	0.00103	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NFKBIA—psoriasis	4.71e-05	0.001	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SOCS1—psoriasis	4.49e-05	0.000959	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—LEP—psoriasis	4.29e-05	0.000917	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APOE—psoriasis	4.29e-05	0.000917	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—TYK2—psoriasis	4.28e-05	0.000915	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCL8—psoriasis	4.11e-05	0.000877	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NFKBIA—psoriasis	4e-05	0.000855	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TYK2—psoriasis	3.85e-05	0.000823	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCL8—psoriasis	3.73e-05	0.000796	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCL8—psoriasis	3.36e-05	0.000717	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APOE—psoriasis	3.31e-05	0.000708	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—LEP—psoriasis	3.31e-05	0.000708	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TYK2—psoriasis	3.28e-05	0.0007	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6—psoriasis	3.19e-05	0.000682	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—JUN—psoriasis	3.12e-05	0.000666	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NFKBIA—psoriasis	3.09e-05	0.00066	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NFKB1—psoriasis	3e-05	0.000641	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCL8—psoriasis	2.85e-05	0.000609	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—VEGFA—psoriasis	2.73e-05	0.000582	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6—psoriasis	2.71e-05	0.000579	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—STAT3—psoriasis	2.7e-05	0.000576	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—JUN—psoriasis	2.65e-05	0.000567	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NFKB1—psoriasis	2.55e-05	0.000545	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TYK2—psoriasis	2.53e-05	0.00054	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—VEGFA—psoriasis	2.32e-05	0.000495	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—STAT3—psoriasis	2.29e-05	0.00049	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL8—psoriasis	2.2e-05	0.000471	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6—psoriasis	2.09e-05	0.000447	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TP53—psoriasis	2.06e-05	0.00044	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—JUN—psoriasis	2.05e-05	0.000437	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NFKB1—psoriasis	1.97e-05	0.000421	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6—psoriasis	1.88e-05	0.000403	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—VEGFA—psoriasis	1.79e-05	0.000382	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—STAT3—psoriasis	1.77e-05	0.000378	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TP53—psoriasis	1.75e-05	0.000374	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6—psoriasis	1.6e-05	0.000342	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TP53—psoriasis	1.35e-05	0.000289	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6—psoriasis	1.24e-05	0.000264	CbGpPWpGaD
